LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector

Human Gene Therapy

Volumn 8, Issue 4, 1997, Pages 439-452

  Huard, Johnny ^a   Akkaraju, Giri ^b   Watkins, Simon C ^b   Pike Cavalcoli, Michele ^b   Glorioso, Joseph C ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL VIABILITY; CLONING VECTOR; CYTOTOXICITY; GENE EXPRESSION; GENE TRANSFER; HERPES SIMPLEX VIRUS 1; HUMAN CYTOMEGALOVIRUS; MOUSE; MUSCLE CELL; MYOBLAST; NEWBORN; NONHUMAN; REPORTER GENE; SKELETAL MUSCLE; ULTRAVIOLET IRRADIATION;

ANIMALIA; ESCHERICHIA COLI; HERPES; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 5;

EID: 0030896088     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.4-439     Document Type: Article

References (67)

1. ACSADI, G., DICKSON, G., LOVE, D.R., JANI, A., WALSH, F.S., GURUSINGHE, A., WOLFF, J.A., and DAVIES, K.E. (1991). Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 352, 815-818.
2. ACSADI, G., JANI, A., MASSIE, B., SIMONEAU, M., HOLLAND, P., BLASCHUK, K., and KARPATI, G.A. (1994a). Differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells at different maturity. Hum. Mol. Gen. 3, 579-584.
3. ACSADI, G., JANI, A., HUARD, J., BLASCHUK, K., MASSIE, B., HOLLAND, P., LOCHMUELLER, H., and KARPATI, G. (1994b). Cultured human myoblasts and myotubes show markedly different transducibility by replication defective adenovirus recombinant. Gene Ther. 1, 338-340.
4. ACSADI, G., LOCHMUELLER, H., JANI, A., HUARD, J., MASSIE, B., PRESCOTT, S., SIMONEAU, M., PETROF, B., and KARPATI, G. (1996). Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum. Gene Ther. 7, 129-140.
5. ALAMEDDINE, H.S., and FARDEAU, M. (1990). Muscle reconstruction by satellite cell graft. J. Neurol. Sci. 99, 126.
6. ALAMEDDINE, H.S., DEHAUPAS, M., and FARDEAU, M. (1989). Regeneration of skeletal muscle fiber from autologous satellite cells multiplied in-vitro. Muscle and Nerve 12, 544-555.
7. ARAHATA, K., ISHIURA, S., ISHIGURO, T., TSUKAHARA, T., SUHARA, Y., EGUCHI, C., ISHIHARA, T., NONAKA, I., OZAWA, E., and SUGITA, H. (1988). Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 333, 861-863.
8. BERNS, K.I. (1996). Parvoviridae: The viruses and their replication. In Fields Virology, 3rd ed. B.N. Fields, D.M. Knipe, P.M. Howley, et al., eds. (Lippincott-Raven Publishers, Philadelphia, New York) pp. 2173-2197.
9. BONILLA, E.C.E., SAMITT, A.F., MIRANDA, A.P., HAYS, G., SALVIATI, S., DIMAURO, S., KUNKEL, L.M., HOFFMAN, E.P., and ROWLAND, L.P. (1988). Duchenne Muscular Dystrophy: Deficiency of dystrophin at the muscle cell surface. Cell 54, 447-452.
10. DANKO, I., FRITZ, J.D., LATENDRESSE, J.S., HERWEIJER, H., SCHULTZ, E., and WOLFF, J.A. (1993). Dystrophin expression improves myofiber survival in mdx muscle following intramuscular plasmid DNA injection. Hum. Mol. Genet. 2, 2055-2061.
11. DAVIES, H.L., WHALEN, R.G., and DEMENEIX, B.A. (1993). Direct gene transfer into skeletal muscle in vivo: Factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4, 151-159.
12. DELUCA, N.A., and SCHAFFER, P.A. (1985). Activation of immediate-early, early and late promoters by temperature sensitive and wildtype forms of herpes simplex virus type #1 protein ICP4. Mol. Cell. Biol. 5, 558-570.
13. DUNCKLEY, M.G., DAVIES, K.E., WALSH, F.S., MORRIS, G.E., and DICKSON, G. (1992). Retroviral-mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro. Febs Lett. 296, 128-134.
14. ENGELHARDT, J.F., LITZKY, L., and WILSON, J.M. (1994a). Prolonged transgene expression in cotton rat lung with recombinant adenovirus defective in E2A. Hum. Gen. Ther. 5, 1217-1229.
15. ENGELHARDT, J.F., YE, X., DORANZ, B., and WILSON, J.M. (1994b). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory responses in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.
16. GAGE, P.J., SAUER, B., LEVINE, M., and GLORIOSO, J.C. (1992). A cell-free recombination system for site-specific integration of multigenic shuttle plasmids into the herpes simplex virus type 1 genome. J Virol. 66, 5509-5515.
17. GLORIOSO, J.C., STERNBERG, L.R., GOINS, W.F., and FINK, D.J. (1992). Development of herpes simplex virus as a gene transfer vector for the central nervous system. In Gene Transfer and Therapy in the Nervous System. F.H. Gage and Y. Christen, eds. (Springer-Verlag, Berlin, Heidelberg) pp. 133-145.
18. GLORIOSO, J.C., GOINS, W.F., FINK, D.J., and DELUCA, N.A. (1994). Herpes simplex virus vectors and gene transfer to brain. In Recombinant Vectors in Vaccine Development, vol. 82. F. Brown, ed. Dev. Biol. Stand. Karger Basel, pp. 79-87.
19. GUSSONI, E., PAVLATH, P.K., LANCTOT, A.M., SHARMA, K., MILLER, R.G., STEINMAN, L., and BLAU, H.M. (1992). Normal dystrophin transcripts detected in DMD patients after myoblast transplantation. Nature 356, 435-438.
20. HAECKER, S.E., STEDMAN, H.H., BALICE-GORDON, R.J., SMITH, D.B.J., GREELISH, J.P., MITCHELL, M.A., WELLS, A., SWEENEY, H.L., and WILSON, J.M. (1996). In vivo expression of full-length human dystrophin from adenoviral vector deleted of all viral genes. Hum. Gene Ther. 7, 1907-1914.
21. HOFFMAN, E.P., BROWN, J., and KUNKEL, L.M. (1987). Dystrophin: The protein product of the Duchenne Muscular Dystrophy locus. Cell 51, 919-928.
22. HUARD, J., LABRECQUE, C., DANSEREAU, G., ROBITAILLE, L., and TREMBLAY, J.P. (1991). Dystrophin expression in myotubes formed by the fusion of normal and dystrophic myoblasts. Muscle and Nerve 14, 178-182.
23. HUARD, J., BOUCHARD, J.P., ROY, R., MALOUIN, F., DANSEREAU, G., LABRECQUE, C., ALBERT, N., RICHARDS, C.L., LEMIEUX, B., and TREMBLAY, J.P. (1992a). Human myoblast transplantation: Preliminary results of four cases. Muscle and Nerve 15, 550-560.
24. HUARD, J., ROY, R., BOUCHARD, J.P., MALOUIN, F., RICHARDS, C.L., and TREMBLAY, J.P. (1992b). Human myoblast transplantation between immunohistocompatible donnors and recipients produces immune reactions. Transpl. Proc. 24, 3049-3051.
25. HUARD, J., ROY, R., GUERETTE, B., VERREAULT, S., TREMBLAY, G., LILLE, S., and TREMBLAY, J.P. (1994a). Human myoblast transplantation in immunodeficient and immunosuppressed mice: Evidence of rejection. Muscle and Nerve 17, 224-234.
26. HUARD, J., VERREAULT, S., ROY, R., TREMBLAY, M., and TREMBLAY, J.P. (1994b). High efficiency of muscle regeneration following human myoblast clone transplantation in SCID mice. J. Clin. Invest. 93, 586-599.
27. HUARD, J., ACSADI, G., JANI, A., MASSIE, B., and KARPATI, G. (1994c). Gene transfer into skeletal muscles by isogenic myoblasts. Hum. Gene Ther. 5, 949-958.
28. HUARD, J., LOCHMUELLER, H., JANI, A., HOLLAND, P., GUERIN, C., MASSIE, B., and KARPATI, G. (1995a). Differential short-term transduction efficiency of adult versus newborn mouse tissues by adenoviral recombinants. Exp. Mol. Pathol. 62, 131-143.
29. HUARD, J., GOINS, B., and GLORIOSO, J.C. (1995b). Herpes Simplex virus type 1 vector mediated gene transfer to muscle. Gene Ther. 2, 1-9.
30. HUARD, J., FEERO, W.G., WATKINS, S.C., HOFFMAN, E.P., ROSENBLATT, D.J., and GLORIOSO, J.C. (1996). The basal lamina is a physical barrier to HSV mediated gene delivery to mature muscle fibers. J. Virol. 70, 8117-8123.
31. JOHNSON, P.A., MIYANOHARA, A., LEVINE, F., CAHILL, T., and FRIEDMANN, T. (1992). Cytotoxicity of a replication-defective mutant of Herpes Simplex virus type 1. J. Virol. 66, 2952-2965.
32. JOHNSON, P.A., WANG, M.J., and FRIEDMANN, T. (1994). Improved cell survival by the reduction of Immediate-early gene expression in replication-defective mutants of Herpes simplex virus type 1 but not by mutation of the virion host shutoff function. J. Virol. 68, 6347-6362.
33. KARPATI, G., and WORTON, R.G. (1992). Myoblast transfer in DMD: problems and interpretation of efficiency. Muscle and Nerve 15, 1209.
34. KARPATI, G., POULIOT, Y., ZUBRZYCKA-GAARN, E.E., CARPENTER, S., RAY, P.N., WORTON, R.G., and HOLLAND, P. (1989). Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am. J. Pathol. 135, 27-32.
35. KINOSHITA, I., VILQUIN, J.T., GUERETTE, B., ASSELIN, I., ROY, R., and TREMBLAY, J.P. (1994). Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle and Nerve 17, 1407-1415.
36. KOCHANEK, S., CLEMENS, P.R., MITANI, K., CHEN, H.H., CHAN, S., AND CASKEY, C.T. (1996). In press. A new adenoviral vector: Replacement of all viral coding sequences with 28 Kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc. Natl. Acad. Sci. USA 93, 5731-5736.
37. KUMAR-SINGH, R., and CHAMBERLAIN, J.S. (1996). Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 Kb dystrophin cDNA to muscle cells. Hum. Mol. Genet. 5, 913-921.
38. LAGUNOFF, M., RANDALL, G., and ROIZMAN, B. (1996). Phenotypic properties of Herpes simplex virus 1 containing a derepressed open reading frame P gene. J. Virol. 70, 1810-1817.
39. LARSSON, L.I. (1988). Immunocytochemistry Theory and Practice. (CRC Press, Boca Raton, FL) pp. 77-130.
40. LAW, P.K., GOODWIN, T.G., and WANG, M.G. (1988). Normal myoblast injections provide genetic treatment for murine dystrophy. Muscle and Nerve 11, 525-533.
41. MENKE, A., and JOKUSH, H. (1991). Decreased osmotic stability of dystrophin less muscle cells from the mdx mice. Nature 349, 69-71.
42. MORGAN, J.E., WATT, D.J., SLOPPER, J.C., and PARTRIDGE, T.A. (1988). Partial correction of an inherited defect of skeletal muscle by graft of normal muscle precursor cells. J. Neurol. Sci. 86, 137-147.
43. MORGAN, J.E., HOFFMAN, E.P., and PARTRIDGE, T.A. (1990). Normal myogenic cells from newborn mice restore normal histology to degenerating muscle of the mdx mouse. J. Cell Biol. 111, 2437-2449.
44. MORGAN, J.E., PAGEL, C.N., SHERRAT, T., and PARTRIDGE, T.A. (1993). Long-term persistence and migration of myogenic cells injected into preirradiated muscles of mdx mice. J. Neurol. Sci. 115, 191-200.
45. PARTRIDGE, T.A., MORGAN, J.E., COULTON, G.R., HOFFMAN, E.P., and KUNKEL, L.M. (1989). Conversion of mdx myofibers from dystrophin negative to positive by injection of normal myoblasts. Nature 337, 176-179.
46. PARTRIDGE, T.A. (1991). Myoblast transfer: A possible therapy for inherited myopathies. Muscle and Nerve 14, 197-212.
47. QUANTIN, B., PERRICAUDET, L.D., TAJBAKHSH, S., and MANDELL, J.L. (1992). Adenovirus as an expression vector in muscle cells in vivo. Proc. Natl. Acad. Sci. USA 89, 2581-2584.
48. RAGOT, T., VINCENT, M., CHAFEY, P., VIGNE, E., GILGENKRANTZ, H., COUTON, B., CARTAUD, J., BRIAND, P., KAPLAN, J.C., PERRICAUDET, M., and KAHN, A. (1993). Efficient adenovirus mediated gene transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361, 647-650.
49. SALVATORI, G., FERRARI, G., MESSOGIORNO, A., SERVIDEL, S., COLETTE, M., TONALLI, P., GIARASSI, R., COSSO, G., and MAVILLO, F. (1993). Retroviral vector-mediated gene transfer into human primary myogenic cells lead to expression in muscle fibers in vivo. Hum. Gene Ther. 4, 713-723.
50. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) pp. 16.59-16.66.
51. SANES, J.R., RUBENSTEIN, J.L.R., and NICOLAS, J.F. (1986). Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5, 5133-5142.
52. SMITH, T.A.G., MEHAFFEY, M.G., KAYDA, D.B., SAUNDERS, J.M., YEI, S., TRAPNELL, B.C., McCLELL, A., and KALEKO, M. (1993). Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genet. 5, 397-402.
53. SPEAR, P.G., (1993). Membrane fusion induced by herpes simplex virus. In Viral Fusion Mechanisms. J. Bentz, ed. (CRC Press, Boca Raton, FL) pp. 201-232.
54. STEVENS, J.G. (1989). Human herpesviruses: A consideration of the latent state. Microbiol. Rev. 53, 318-332.
55. SUGITA, H., ARAHATA, K., ISHIGURO, T., SOHARA, Y., TSUKAHARA, T., ISHIURA, J., EGUCHI, C., NONAKA, I., and OZAWA, E. (1988). Negative immunostaining of Duchenne Muscular Dystrophy (DMD) and mdx muscle surface membrane with antibody against synthetic peptide fragment predicted from DMD cDNA. Proc. Japan. Acad. 64, 37-39.
56. TREMBLAY, J.P., BOUCHARD, J.P., MALOUIN, F., THEAU, D., COTTRELL, F., COLLIN, H., ROUCHE, A., GILGENKRANTZ, S., ABBDI, N., and TREMBLAY, M. (1993a). Myoblast transplantation between monozygotic twin girl carriers of Duchenne Muscular Dystrophy. Neuromusc. Disorders 3, 583-592.
57. TREMBLAY, J.P., MALOUIN, F., ROY, R., HUARD, J., BOUCHARD, J.P., SATOH, A., and RICHARDS, C.L. (1993b). Results of a blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne Muscular Dystrophy. Cell. Transplant. 2, 99-112.
58. VILQUIN, J.T., WAGNER, E., KINOSHITA, I., ROY, R., and TREMBLAY, J.P. (1995a). Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin. J. Cell Biol. 131, 975-988.
59. VILQUIN, J.T., GUERETTE, B., KINOSHITA, I., ROY, B., GOULET, M., GRAVEL, C., ROY, R., and TREMBLAY, J.P. (1995b). FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Hum. Gene Ther. 6, 1391-1401.
60. VINCENT, M., RAGOT, T., GILGENKRANTZ, H., COUTON, D., CHAFEY, P., GREGOIRE, A., BRIAND, P., KAPLAN, J.C., KAHN, A., and PERRICAUDET, M. (1993). Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nature Genet. 5, 130-134.
61. WATKINS, S.C., HOFFMAN, E.P., SLAYTER, H.S., and KUNKEL, L.M. (1988). Immunoelectron microscopic localization of dystrophin in myofibers. Nature 333, 863-866.
62. WATT, D.J., LAMBERT, K., MORGAN, J.E., PARTRIDGE, T.A., and SLOPER, J.C. (1982). Incorporation of donor muscle precursor cells into an area of muscle regeneration in the host mouse. J. Neurol. Sci. 57, 319-331.
63. WATT, D.J., MORGAN, J.E., and PARTRIDGE, T.A. (1984). Use of mononuclear precursor cells to insert allogenic genes into growing mouse muscles. Muscle and Nerve 7, 741-750.
64. WEBSTER, C., and BLAU, H.M. (1990). Acelerated age-related decline in replicative life span of Duchenne Muscular Dystrophy myoblasts. Implications for cell and gene therapy. Somat. Cell Mol. Genet. 16, 557-565.
65. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONCZOL, E., and WILSON, J.M. (1994a). Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
66. YANG, Y., NUNES, F.A., BERENCSI, K., GONCZOL, E., ENGELHARDT, J.F., and WILSON, J.M. (1994b). Inactivation of E2A in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet. 7, 362-369.
67. ZUBRYZCKA-GAARN, E.E., BULMAN, D.E., KARPATI, G., BURGHES, A.H.M., BELFALL, B., KLAMUT, H.J., TALBOT, J., HODGES, R.S., RAY, P.N., and WORTON, R.G. (1988). The Duchenne Muscular Dystrophy gene is localized in the sarcolemma of human skeletal muscle. Nature 333, 466-469.